相关实验视频

Updated: Jun 16, 2025

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

在低氧的情况下,TH-302 (evofosfamide) 单疗对Ewing瘤细胞具有抗癌活性

Marie Kühne^1,2,3, Sabine Becker^1,4,3, Jürgen Sonnemann^1,4,3

¹Department of Pediatric and Adolescent Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

|June 14, 2025

概括

低氧激活的前药TH-302有效地破坏DNA,并减少了Ewing细胞的细胞数量.

科学领域:

在瘤学瘤学.
癌症生物学癌症生物学
药理学药理学是一个学科.

背景情况:

瘤缺氧是癌症进展,转移和抗治疗的关键因素.
低氧激活前期药物 (HAPs) 旨在专门针对和激活在低氧瘤环境中的瘤.
TH-302 (evofosfamide) 是一种先进的HAP,因其治疗潜力而受到研究.

研究的目的:

为了评估TH-302对尤文肉瘤 (ES) 细胞系的影响.
为了确定TH-302在不同氧度下的疗效.

主要方法:

使用流细胞计和qRT-PCR评估了DNA损伤,增殖,细胞死亡,线粒体脱极化和酶激活.
在正常和缺氧条件下比较TH-302对ES细胞的影响.
研究了p53状态在TH-302的作用机制中的作用.

主要成果:

在ES细胞中,TH-302诱导了显著的DNA损伤和减少细胞数量 (> 60%),特别是在低氧状态下.
TH-302引发细胞死亡 (高达40%) 和线粒体脱极化 (高达60%) 最好在低氧条件下.
-3/7激活和亚G1种群在缺氧下增加,最大效应在0.2%O₂.

结论:

试管测试结果表明TH-302对尤文肉瘤的潜在疗效.
这些发现支持进一步的体内研究,以探索TH-302作为ES的治疗方法.

关键词:

癌症治疗治疗癌症治疗尤文的肉瘤是尤文的肉瘤.低氧激活前药物 (HAP) 是一种低氧激活前药物.在P53中,P53是P53 TH-302 (埃沃胺) 的使用情况瘤缺氧是因为瘤缺氧.

更多相关视频

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...